Won-Sik Shin
6PUBLICATIONS
2CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Aug 12, 2023
Knockdown of PTK7 Reduces the Oncogenic Potential of Breast Cancer Cells by Impeding Receptor Tyrosine Kinase Signaling.Won-Sik Shin, Si Won Oh, Han Na Park
|Oct 27, 2022
Anti-PTK7 Monoclonal Antibodies Exhibit Anti-Tumor Activity at the Cellular Level and in Mouse Xenograft Models of Esophageal Squamous Cell Carcinoma.Jae Hoon Kim, Won-Sik Shin, Se-Ra Lee
|Sep 23, 2022
Anti-PTK7 Monoclonal Antibodies Inhibit Angiogenesis by Suppressing PTK7 Function.Si Won Oh, Won-Sik Shin, Seung-Taek Lee
|Feb 26, 2022
PTK7, a Catalytically Inactive Receptor Tyrosine Kinase, Increases Oncogenic Phenotypes in Xenograft Tumors of Esophageal Squamous Cell Carcinoma KYSE-30 Cells.Won-Sik Shin, Mi-Kyung Park, Jae Hoon Kim
|Jul 10, 2020
The catalytically defective receptor protein tyrosine kinase EphA10 promotes tumorigenesis in pancreatic cancer cells.Won-Sik Shin, Mi Kyung Park, Young Hun Lee
|Jun 06, 2018
Biphasic regulation of tumorigenesis by PTK7 expression level in esophageal squamous cell carcinoma.Won-Sik Shin, Jungsoo Gim, Sungho Won
Pageof 1
